Biogen inc stock.
On average, Biogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $3,042,890. The most recent stock trade was executed by Michael R Mcdonnell on 1 September 2023, trading 5,285 units of BIIB stock currently worth $1,322,941. Sold (or bought if negative) in USD SCANGOS G….
What is Biogen Inc. (BIIB)'s stock price history? Over the last year, Biogen Inc.’s stock price has decreased by 25.02%. Biogen Inc. is currently approximately $227.41 per share.Dec 3, 2023 · Market Average Movement. 6.0%. 10% most volatile stocks in US Market. 15.4%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: BIIB is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week. Volatility Over Time: BIIB's weekly volatility (3%) has been stable over the past year. Sep 12, 2023 · In the latest trading session, Biogen Inc. (BIIB) closed at $258.44, marking a -0.19% move from the previous day. This change was narrower than the S&P 500's 0.57% loss on the day. Biogen Inc (BIIB) stock has risen 2.66% while the S&P 500 has fallen -0.49% as of 11:16 AM on Wednesday, Apr 5. BIIB has gained $7.31 from the previous closing price of $275.25 on volume of 296,402 shares. Over the past year the S&P 500 is lower by -9.83% while BIIB has gained 36.10%. BIIB earned $20.87 a per share in the over the last 12 ...Biogen to host investor conference call today at 9:00 a.m. ET. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Reata Pharmaceuticals, Inc ...
Biogen Inc. (BIIB) stock forecast and price target. Find the latest Biogen Inc. BIIB analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Get Biogen Inc historical price data for BIIB stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.Key Points. Biogen's planned acquisition will add an important product to its portfolio. The company's new Alzheimer's treatment should help it return to growth, too. Even with these developments ...
Live Chat Inc. is a tool you can use to interact with customers or clients on the internet. More and more, consumers are demanding and expecting immediate help from the companies they approach. This application enables you to engage with cu...Nov 27, 2023 · Get Biogen Inc (BIIB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ... Biogen Inc BIIB.O. Official Data Partner. Latest Trade ... See Biogen Inc. (BIIB) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. BIIB Stock Overview. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United …Biogen Inc. Common Stock (BIIB) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
The low in the last 52 weeks of Biogen stock was 220.86. According to the current price, Biogen is 108.22% away from the 52-week low. What was the 52-week high for Biogen stock?
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of …
Find the latest Eisai Co., Ltd. (4523.T) stock quote, history, news and other vital information to help you with your stock trading and investing.Biogen-Sage Therapeutics postpartum depression pill priced at $15,900. Biogen and Sage Therapeutics' oral pill to treat postpartum depression (PPD) in adults is expected to cost U.S. wholesalers $15,900 for a full 14-day treatment, Sage Therapeutics said on Tuesday. Other symbols:138.99M. -77.03%. Get the latest Biogen Inc (BIIB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment... Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (78.5%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (16.7%) ; - other (4.8%): primarily revenues …Mar 17, 2023 · Biogen Inc. is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Vertex Pharmaceuticals (VRTX), a stock from the same industry, has gained 2.9%. Biogen's stock surged 50% in early premarket trading. Shares of Eisai jumped 17% to the daily limit in Tokyo. Shares of Roche, which is expected to report results on a rival Alzheimer's drug ...
Mar 8, 2023 · Cambridge, Mass. – March 8, 2023 – Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that the U.S. Food and Drug Administration (FDA) notified the companies that the agency does not currently plan to convene an advisory committee meeting to discuss the New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum ... Biogen Company Info. Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases.Biogen Inc. (BIIB) Acquiree: Reata Pharmaceuticals, Inc. (RETA) Details: Biogen Inc. (NASDAQ:BIIB) - has completed the acquisition of Reata Pharmaceuticals, Inc. (NASDAQ:RETA), a company focused on developing therapeutics that regulate cellular metabolism and inflammation in serious neurologic diseases.The average Biogen stock price prediction forecasts a potential upside of 37.78% from the current BIIB share price of $234.64. What is BIIB's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BIIB ) forecast ROE is N/A , which is considered weak . Biogen Inc. (BIIB) closed at $269.98 in the latest trading session, marking a -0.02% move from the prior day. This change lagged the S&P 500's daily gain of 0.17%. Meanwhile, the Dow gained 0.6% ...See the latest Biogen Inc stock price (BIIB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.
You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Biogen Inc. is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Vertex Pharmaceuticals (VRTX), a stock from the same industry, has gained 2.9%.CAMBRIDGE, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – has completed the acquisition of Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a company focused on developing therapeutics that regulate cellular metabolism and inflammation in serious neurologic diseases. As a result of the transaction, Biogen has now acquired ...Nikkei 225. 33,447.67. -0.53%. Negative. Source: LSEG - data delayed by at least 15 minutes. Get Biogen Inc (BIIB.OQ) real-time stock quotes, news, price and financial information from Reuters to ...Biogen Inc. (BIIB) closed the most recent trading day at $283.44, moving -1.94% from the previous trading session. This change was narrower than the S&P 500's daily loss of 2.49%. Meanwhile, the ...1 BIIB = 229.46 USD 1 month 6 months 1 year 5 years Biogen Inc stock performance at a glance Check Biogen Inc’s past financial performance, like revenue or net income, plus …
The following ETFs maintain exposure to Biogen Inc. ( BIIB ). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
Hayward Pool Products Inc is a leading manufacturer of high-quality pool equipment, including pumps, filters, heaters, and cleaners. If you’re lucky enough to own one of their products, it’s important to keep it in good condition to ensure ...
Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Biogen (BIIB) In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Biogen, with a price target of $280.00 . The company’s shares closed last Thursday at $234.08 ...Biogen Inc stock performance at a glance. Check Biogen Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Biogen and Sage enter into an agreement to jointly develop and commercialize zuranolone and SAGE-324 in the U.S.; Biogen to receive exclusive license to develop and commercialize zuranolone and SAGE-324 outside of the U.S., excluding rights to zuranolone in Japan, Taiwan and South Korea; Sage Therapeutics to receive …Sep 12, 2023 · In the latest trading session, Biogen Inc. (BIIB) closed at $258.44, marking a -0.19% move from the previous day. This change was narrower than the S&P 500's 0.57% loss on the day. Biogen Inc. (BIIB) closed the most recent trading day at $283.44, moving -1.94% from the previous trading session. This change was narrower than the S&P 500's daily loss of 2.49%.CAMBRIDGE, Mass., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for major depressive disorder (MDD), postpartum depression (PPD) and other psychiatric ...The following ETFs maintain exposure to Biogen Inc. ( BIIB ). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
The average Biogen stock price prediction forecasts a potential upside of 37.78% from the current BIIB share price of $234.64. What is BIIB's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BIIB ) forecast ROE is N/A , which is considered weak . Biogen (BIIB-0.60%) is an intriguing stock right now. Its business has struggled to generate growth in recent years, but some recent catalysts could turn things around. For starters, the company's ...CAMBRIDGE, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – has completed the acquisition of Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a company focused on developing ...Instagram:https://instagram. presidential betting linesnurse malpractice insurance companiesbest broker for automated tradingbest fha lenders in nj In addition, Biogen Inc. has a VGM Score of C (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). companies investing in real estateafirm stock The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts.Oct 11, 2023. Cambridge, Mass.— Biogen Inc . (Nasdaq:BIIB) today announced it will report third quarter 2023 financial results Wednesday, November 8, 2023, before the financial markets open. Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m. ET. beigene limited U.S.: Nasdaq Watchlist market open $ 232.65 BIIB 0.59 0.25% Nov 30, 2023 12:30 p.m. EST Real Time Quote About Biogen Inc. Biogen, Inc. is a …Live Chat Inc. is a tool you can use to interact with customers or clients on the internet. More and more, consumers are demanding and expecting immediate help from the companies they approach. This application enables you to engage with cu...